in the multi-institutional phase ii studies , clinical activity of 5'-dfur was found in head and neck , thyroidal , esophageal , gastric , colo-rectal , gall-bladder and breast cancers at daily doses of 800-1,200 mg/body .
C0027530
neck
C0040132
thyroidal